Table 11.
The aspartate aminotransferase content (U/L).
| Groups | 1 dpi | 4 dpi | 8 dpi |
|---|---|---|---|
| Uninfected-untreated control | 220.46 ± 11.77 a | 223.22 ± 12.06 a | 230.62 ± 23.95 a |
| Infected-untreated control | 222.56 ± 14.18 a | 263.46 ± 9.28 b | 275.9 ± 10.79 c |
| ShiYingZi-PL | 216.3 ± 13.94 a | 256.66 ± 11.08 b | 259.28 ± 7.49 b |
| ShiYingZi-PM | 214.38 ± 17.06 a | 254.54 ± 7.25 b | 250.12 ± 5.36 b |
| ShiYingZi-PH | 214.1 ± 14.39 a | 251.3 ± 7.11 b | 251.32 ± 12.03 b |
| Monensin | 224.34 ± 8.5 a | 263.3 ± 11.9 b | 253.08 ± 6.31 b |
| ShiYingZi-TL | 224.20 ± 9.78 a | 258.33 ± 10.69 b | 264.03 ± 9.18 b |
| ShiYingZi-TM | 232.33 ± 8.88 a | 263.73 ± 16.22 b | 267.37 ± 20.15 b |
| ShiYingZi-TH | 220.50 ± 11.05 a | 264.50 ± 9.97 b | 264.43 ± 21.63 b |
| Sulfachloropyrazine sodium | 230.50 ± 9.10 a | 263.43 ± 19.90 b | 254.07 ± 0.36 b |
a,b,c Significant differences exist when there are different letters in each column (p < 0.05). n = 5.